Rightslink® by Copyright Clearance Center

Risk stratification using the Merlin Assay (CP-GEP) in an independent cohort of 930 patients with clinical stage I/II melanoma who did not undergo sentinel lymph node biopsy

Author:

Teresa Amaral,Eftychia Chatziioannou,Alica Nuebling,Lena Nanz,Tobias Sinnberg,Heike Niessner,Tim Arentsen,Romy Ruiter,Jvalini Dwarkasing,Alexander M. Eggermont,Ulrike Leiter,Lukas Flatz,Stephan Forchhammer

Publication:

European Journal of Cancer

Publisher:

Elsevier

Date:

2 May 2025

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Creative Commons

This is an open access article distributed under the terms of the Creative Commons CC-BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article.